secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2025-09-26T23:59:59+00:00
Accession:  0001023024-25-000099
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 3.02, 3.03
LLM model:  deepseek-v4-flash:cloud@v2

ANI converts all Series A preferred to common; 602,900 shares issued, preferred eliminated
--------------------------------------------------------------------------------

- On Sep 26, 2025, ANI mandatorily converted 20,000 preferred shares into 482,320 common shares at $41.4662/share.
- On Aug 14, 2025, Ampersand converted 5,000 preferred shares into 120,580 common shares at the same price.
- All 25,000 preferred shares converted into 602,900 common shares; no preferred shares remain outstanding.
- Mandatory conversion triggered because 20-day VWAP exceeded 170% of conversion price ($70.50) after second anniversary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000102302425000099/0001023024-25-000099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000102302425000099/ani-20250926.htm
  HTML page:      https://secwatch.observer/filing/0001023024-25-000099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer